您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报（医学版） ›› 2016, Vol. 54 ›› Issue (5): 45-49.doi: 10.6040/j.issn.1671-7554.0.2016.020

• • 上一篇    下一篇

ER、PR在妊娠期子宫肌瘤组织中的表达及意义

刘冉1,陶国伟2,甄军晖3,罗霞1,千日成4   

  1. 1.山东大学齐鲁医院妇产科, 山东 济南 250012;2.山东大学齐鲁医院超声科, 山东 济南 250012;3.山东大学齐鲁医院病理科, 山东 济南 250012;4.南京医科大学生殖医学国家重点实验室, 江苏 南京 210029
  • 收稿日期:2016-01-06 出版日期:2016-05-16 发布日期:2016-05-16
  • 通讯作者: 罗霞. E-mail:luoxia0311@163.com E-mail:luoxia0311@163.com
  • 基金资助:
    生殖医学国家重点实验室开放基金(SKLRM-KF-1303)

Expression and significance of ER and PR in fibroids and myometrium during pregnancy

LIU Ran1, TAO Guowei2, ZHEN Junhui3, LUO Xia1, QIAN Richeng4   

  1. 1. Department of Obstetrics and Gynecology;
    2. Department of Ultrasonography;
    3. Department of Pathology, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China;
    4. State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing 210029, Jiangsu, China
  • Received:2016-01-06 Online:2016-05-16 Published:2016-05-16

PDF (PC)

601

摘要： 目的 探讨雌激素受体(ER)、孕激素受体(PR)在妊娠期子宫肌瘤组织中的表达及意义。 方法 (1)随机选取9例妊娠期患者的子宫肌瘤(A组)及相应的正常子宫平滑肌组织(B组)、12例非妊娠期患者的子宫肌瘤(C组)及相应的正常子宫平滑肌组织(D组),应用免疫组化SP法分别检测ER、PR在4种组织中的表达。(2)随机选择110例妊娠合并子宫肌瘤的孕妇作为研究对象,通过彩色超声检查结果统计子宫肌瘤在妊娠早期(妊娠13周以内)、妊娠中期(妊娠16~23周)和妊娠晚期(妊娠37~40周)的大小。 结果 (1)ER在A组与B组中表达均为阴性,PR在A组中的表达水平明显高于B组(P=0.033)。ER、PR在A组中的表达水平均明显低于C组(P=0.000; P=0.001);(2)妊娠早、中、晚期子宫肌瘤大小差异无统计学意义(P=0.741),但妊娠中、晚期与妊娠早期相比,子宫肌瘤有增大趋势,妊娠晚期与妊娠中期相比,子宫肌瘤有缩小趋势。 结论 ER、PR可能在妊娠期子宫肌瘤的生长中发挥重要作用,而ER缺失是否与妊娠期高雌、孕激素状态下子宫肌瘤生长缓慢有关值得进一步探讨。

关键词: 妊娠, 子宫肌瘤, 雌激素受体, 孕激素受体

Abstract: Objective To explore the expression and significance of ER and PR in fibroids and myometrium during pregnancy. Methods (1) We collected 9 pregnant womens fibroids(group A)and myometrium(group B), and 12 non-pregnant womens fibroids(group C)and myometrium(group D). The expressions of ER and PR in these tissues were detected with immunohistochemistry. (2) We selected 110 pregnant women with fibroids as the research objects, and recorded the sizes of fibroids through ultrasonic reports in early pregnancy(less than 13 weeks), mid pregnancy(16 to 23 weeks gestation)and late pregnancy(37 to 40 weeks gestation). Results (1) The expressions of ER in group A and B were negative. The expression of PR in group A was significantly higher than that in group B(P=0.033). The expressions of ER and PR in group A were significantly lower than those in group C(P=0.000, P=0.001). (2) There was no significant difference in the sizes of fibroids between early mid and late pregnancy(P=0.741). But fibroids had an 山 东 大 学 学 报 (医 学 版)54卷5期 -刘冉,等.ER、PR在妊娠期子宫肌瘤组织中的表达及意义 \=-increasing trend in early and mid pregnancy and had a decreasing trend in late pregnancy. Conclusion ER and PR may play an important role in the growth of fibroids during pregnancy. However, whether ER deletion is related to the slow growth of fibroids with high estrogen and progesterone during pregnancy still remains unclear.

Key words: Progesterone receptor, Pregnancy, Uterine fibroids, Estrogen receptor

中图分类号: 

  • R714.2
[1] Al-Hendy A, Diamond MP, El-Sohemy A, et al. 1,25-dihydroxyvitamin D3 regulates expression of sex steroid receptors in human uterine fibroid cells[J]. J Clin Endocrinol Metab, 2015, 100(4): E572-582.
[2] Eze CU, Odumeru EA, Ochie K, et al. Sonographic assessment of pregnancy co-existing with uterine leiomyoma in Owerri, Nigeria[J]. Afr Health Sci, 2013, 13(2): 453-460.
[3] Laughlin SK, Schroeder JC, Baird DD. New directions in the epidemiology of uterine fibroids[J]. Semin Reprod Med, 2010, 28(3): 204-217.
[4] Saegusa M, Okayasu I. Changes in expression of estrogen receptors alpha and beta in relation to progesterone receptor and pS2 status in normal and malignant endometrium[J]. Jpn J Cancer Res, 2000, 91(5): 510-518.
[5] Flierman PA, Oberyé JJ, van der Hulst VP, et al. Rapid reduction of leiomyoma volume during treatment with the GnRH antagonist ganirelix[J]. BJOG, 2005, 112(5): 638-642.
[6] Shao R, Fang L, Xing R, et al. Differential expression of estrogen receptor α and β isoforms in multiple and solitary leiomyomas[J]. Biochem Biophys Res Commun, 2015, 468(1-2): 136-142.
[7] Islam MS, Protic O, Giannubilo SR, et al. Uterine leiomyoma: available medical treatments and new possible therapeutic options[J]. J Clin Endocrinol Metab, 2013, 98(3): 921-934.
[8] Bulun SE, Moravek MB, Yin P, et al. Uterine leiomyoma stem cells: linking progesterone to growth[J]. Semin Reprod Med, 2015, 33(5): 357-365.
[9] Borahay MA, Al-Hendy A, Kilic GS, et al. Signaling pathways in leiomyoma: understanding pathobiology and implications for therapy[J]. Mol Med, 2015, 21(1): 242-256.
[10] 李亮, 宋成文, 杨赛花, 等. IGF-Ⅰ、IGF-Ⅱ、ER及PR在子宫组织的表达及肌瘤复发的意义[J]. 中国妇幼保健, 2015, 30(17): 2874-2876. LI Liang, SONG Chengwen, YANG Saihua, et al. Expressions and significance of IGF-Ⅰ, IGF-Ⅱ, ER, and PR in uterus[J]. Maternal & Child Health Care of China, 2015, 30(17): 2874-2876.
[11] Shaik NA, Lone WG, Khan IA, et al. Enhanced transcription of estrogen receptor α and mitochondrial cytochrome b genes in uterine leiomyomas[J]. Gynecol Endocrinol, 2011, 27(12): 1094-1098.
[12] Tsigkou A, Reis FM, Lee MH, et al. Increased progesterone receptor expression in uterine leiomyoma: correlation with age, number of leiomyomas, and clinical symptoms[J]. Fertil Steril, 2015, 104(1): 170-175.
[13] Kawaguchi K, Fujii S, Konishi I, et al. Immunohistochemical analysis of oestrogen receptors, progesterone receptors and Ki-67 in leiomyoma and myometrium during the menstrual cycle and pregnancy[J]. Virchows Arch A Pathol Anat Histopathol, 1991, 419(4): 309-315.
[14] Moravek MB, Yin P, Ono M, et al. Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications[J]. Hum Reprod Update, 2015, 21(1): 1-12.
[15] Okumu LA, Forde N, Fahey AG, et al. The effect of elevated progesterone and pregnancy status on mRNA expression and localisation of progesterone and oestrogen receptors in the bovine uterus[J]. Reproduction, 2010, 140(1): 143-153.
[16] Godinjak Z, Bilalovic N. Estrogen and progesterone receptors in endometrium in women with unexplained infertility[J]. Mater Sociomed, 2014, 26(1): 51-52.
[17] Hammoud AO, Asaad R, Berman J, et al. Volume change of uterine myomas during pregnancy: do myomas really grow?[J]. J Minim Invasive Gynecol, 2006, l3(5): 386-390.
[18] Neiger R, Sonek JD, Croom CS, et al. Pregnancy-related changes in the size of uterine leiomyomas[J]. J Reprod Med, 2006, 51(9): 671-674.
[1] 韩馨玮,牛月,魏代敏. 激素替代方案准备内膜的冻胚移植前雌激素治疗时间对新生儿体质量的影响[J]. 山东大学学报 (医学版), 2025, 63(11): 46-52.
[2] 王瑞,于康,刘燕萍. 维生素K2与妊娠及妊娠相关疾病的研究进展[J]. 山东大学学报 (医学版), 2024, 62(8): 9-17.
[3] 杜娟,李秀芳,李元美,王慧丹. 孕康颗粒对冻融胚胎移植周期妊娠结局的影响[J]. 山东大学学报 (医学版), 2024, 62(7): 84-90.
[4] 赵振东,张红媛,王谢桐. 上腹部占位的孕妇确诊为糖原累积症Ia型1例[J]. 山东大学学报 (医学版), 2024, 62(5): 121-124.
[5] 林欣仪,黄艳茜,邱嫔,邓高丕. 残角子宫侧输卵管妊娠1例并文献分析[J]. 山东大学学报 (医学版), 2024, 62(4): 116-119.
[6] 曹丹凤,李慧. 儿童期不良经历对妊娠期抑郁症状的影响:母胎依恋的中介作用[J]. 山东大学学报 (医学版), 2024, 62(3): 87-91.
[7] 赵圣蕊,曲慧灵,许鑫鑫,张芳芳,颜磊. 体外受精/卵胞浆内单精子注射-胚胎移植后稽留流产采用药物流产和清宫术效果比较[J]. 山东大学学报 (医学版), 2024, 62(2): 69-74.
[8] 李军秀,袁莹莹,黄凌燕,赵君利. 子宫内膜CD38表达对胚胎移植前抗炎治疗的临床价值[J]. 山东大学学报 (医学版), 2023, 61(8): 54-60.
[9] 刘昶,王倩男,张悦,陈忠绍,褚然,姚舒. 卵巢交界性肿瘤保留生育功能术后肿瘤预后及妊娠结局[J]. 山东大学学报 (医学版), 2023, 61(8): 61-66.
[10] 张娜娜,赵一鸣,刘新敏. 基于两样本孟德尔随机化探索子宫肌瘤与乳腺癌的因果关系[J]. 山东大学学报 (医学版), 2023, 61(8): 86-93.
[11] 许月明,张杰,姜蕾,尹力,赵畔,许欣,郝桂敏. 扳机日孕酮升高与获卵数对辅助生殖技术新鲜周期妊娠结局的影响[J]. 山东大学学报 (医学版), 2023, 61(5): 44-50.
[12] 执笔专家: 班艳丽, 赵颖, 李桦, 刘薇, 荣风年, 赵淑萍, 崔保霞. 剖宫产子宫瘢痕妊娠实用临床分型诊治专家共识[J]. 山东大学学报 (医学版), 2023, 61(11): 1-10.
[13] 宋敏,曹鲁泉,吴利龙,吴淑霞,刘静,张娟,刘翠英. 9例产科A族链球菌感染临床分析[J]. 山东大学学报 (医学版), 2023, 61(11): 89-95.
[14] 张丽霞,田一正,吕尚格,张亚男,颜磊. GnRH-a预处理对子宫内膜异位症患者替代方案冻胚移植结局的影响[J]. 山东大学学报 (医学版), 2023, 61(10): 63-68.
[15] 慈倩倩,武胜英,万秋花,马运荣,赵建文,张健. 10 265例高龄孕妇的产前筛查与诊断方法分析[J]. 山东大学学报 (医学版), 2023, 61(1): 51-57.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发